Biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins.
Depixus has raised €31M across 1 funding round from 4 investors, most recently a Series A round in Dec 2021. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-16 | Series A | €31M |
| Arix Bioscience,Casdin Capital,Lansdowne Partners,PSIM fund |
| View deal → |
